Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Tango Therapeutics (TNGX) EBT Margin (2020 - 2025)

Tango Therapeutics (TNGX) has 6 years of EBT Margin data on record, last reported at 29.5% in Q3 2025.

  • For Q3 2025, EBT Margin rose 28034.0% year-over-year to 29.5%; the TTM value through Dec 2025 reached 162.85%, up 14639.0%, while the annual FY2025 figure was 162.85%, 14639.0% up from the prior year.
  • EBT Margin reached 29.5% in Q3 2025 per TNGX's latest filing, up from 1220.31% in the prior quarter.
  • Across five years, EBT Margin topped out at 29.5% in Q3 2025 and bottomed at 1220.31% in Q2 2025.
  • Average EBT Margin over 5 years is 411.13%, with a median of 419.8% recorded in 2022.
  • Peak YoY movement for EBT Margin: surged 28926bps in 2023, then crashed -109208bps in 2025.
  • A 5-year view of EBT Margin shows it stood at 382.59% in 2021, then fell by -18bps to 452.49% in 2022, then decreased by -25bps to 565.57% in 2023, then plummeted by -62bps to 913.8% in 2024, then soared by 103bps to 29.5% in 2025.
  • Per Business Quant database, its latest 3 readings for EBT Margin were 29.5% in Q3 2025, 1220.31% in Q2 2025, and 738.91% in Q1 2025.